Gary Kobinger

11.8k total citations · 2 hit papers
145 papers, 5.2k citations indexed

About

Gary Kobinger is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gary Kobinger has authored 145 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Infectious Diseases, 53 papers in Epidemiology and 26 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gary Kobinger's work include Viral Infections and Outbreaks Research (70 papers), Viral Infections and Vectors (62 papers) and SARS-CoV-2 and COVID-19 Research (21 papers). Gary Kobinger is often cited by papers focused on Viral Infections and Outbreaks Research (70 papers), Viral Infections and Vectors (62 papers) and SARS-CoV-2 and COVID-19 Research (21 papers). Gary Kobinger collaborates with scholars based in Canada, United States and China. Gary Kobinger's co-authors include James M. Wilson, Gary Wong, Xiangguo Qiu, Amadou Alpha Sall, Lothar H. Wieler, Juliet Bedford, Delia Enría, Ziad A. Memish, Myoung‐don Oh and Dominique Heymann and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Gary Kobinger

142 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COVID-19: towards controlling of a pandemic

2020 1.1k citations Gary Kobinger et al. profile →
Nanozyme-strip for rapid local diagnosis of Ebola

2015 314 citations Gary Kobinger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary Kobinger Canada	36	2.6k	1.1k	1.1k	574	545	145	5.2k
Siddappa N. Byrareddy United States	28	3.0k 1.1×	783 0.7×	1.1k 1.0×	528 0.9×	202 0.4×	122	6.8k
Andrea Marzi United States	49	6.7k 2.5×	2.5k 2.2×	1.1k 1.0×	615 1.1×	549 1.0×	167	8.4k
Darryl Falzarano Canada	30	4.1k 1.5×	690 0.6×	686 0.6×	259 0.5×	168 0.3×	69	5.2k
Wanpen Chaicumpa Thailand	43	3.0k 1.1×	882 0.8×	1.7k 1.6×	606 1.1×	603 1.1×	261	8.8k
Robert F. Garry United States	43	3.2k 1.2×	1.9k 1.7×	1.6k 1.5×	882 1.5×	568 1.0×	227	7.1k
Gene G. Olinger United States	44	4.2k 1.6×	1.5k 1.4×	989 0.9×	469 0.8×	273 0.5×	91	5.8k
Qiuwei Pan Netherlands	46	2.0k 0.7×	1.9k 1.7×	2.2k 2.1×	271 0.5×	445 0.8×	235	7.9k
Jason Kindrachuk Canada	33	1.7k 0.6×	582 0.5×	1.6k 1.5×	252 0.4×	137 0.3×	89	5.0k
Markus Eickmann Germany	29	2.6k 1.0×	946 0.9×	571 0.5×	276 0.5×	206 0.4×	74	4.1k
Neeltje van Doremalen United States	27	4.5k 1.7×	676 0.6×	662 0.6×	348 0.6×	194 0.4×	60	6.3k

Countries citing papers authored by Gary Kobinger

Since Specialization

Citations

This map shows the geographic impact of Gary Kobinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Kobinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Kobinger more than expected).

Fields of papers citing papers by Gary Kobinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Kobinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Kobinger. The network helps show where Gary Kobinger may publish in the future.

Co-authorship network of co-authors of Gary Kobinger

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Kobinger. A scholar is included among the top collaborators of Gary Kobinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Kobinger. Gary Kobinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ao, Zhujun, Hiva Azizi, Maggie Jing Ouyang, et al.. (2024). UV-Inactivated rVSV-M2e-Based Influenza Vaccine Protected against the H1N1 Influenza Challenge. Frontiers in Bioscience-Landmark. 29(5). 195–195. 2 indexed citations

Bushmaker, Trenton, Friederike Feldmann, Jamie Lovaglio, et al.. (2023). Limited Benefit of Postexposure Prophylaxis With VSV-EBOV in Ebola Virus–Infected Rhesus Macaques. The Journal of Infectious Diseases. 228(Supplement_7). S721–S729. 4 indexed citations

Carbonneau, Julie, Charles Joly Beauparlant, Thierry Vincent, et al.. (2023). Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13. The CRISPR Journal. 6(4). 369–385. 2 indexed citations

Azizi, Hiva, Yue Li, Alice Berger, et al.. (2023). Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV. Vaccines. 11(5). 977–977. 1 indexed citations

Bente, Dennis A., Scott C. Weaver, Gary Kobinger, et al.. (2022). Texas professionals are employing a one health approach to protect the United States against biosecurity threats. One Health. 15. 100431–100431.

Ho, Jeffrey, Benoit Laffont, Jonathan Laugier, et al.. (2021). Altered microRNA Transcriptome in Cultured Human Liver Cells upon Infection with Ebola Virus. International Journal of Molecular Sciences. 22(7). 3792–3792. 11 indexed citations

Shahhosseini, Nariman, Gary Wong, Jeremy V. Camp, et al.. (2021). Crimean-Congo Hemorrhagic Fever Virus in Asia, Africa and Europe. Microorganisms. 9(9). 1907–1907. 73 indexed citations

Faria, Sara Socorro, et al.. (2021). The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19. Frontiers in Medicine. 8. 615333–615333. 28 indexed citations

Pasquarelli-do-Nascimento, Gabriel, et al.. (2020). Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity. Frontiers in Endocrinology. 11. 530–530. 69 indexed citations

10.

Kozak, Robert, Mia J. Biondi, Anna Majer, et al.. (2020). Dual RNA-Seq characterization of host and pathogen gene expression in liver cells infected with Crimean-Congo Hemorrhagic Fever Virus. PLoS neglected tropical diseases. 14(4). e0008105–e0008105. 16 indexed citations

11.

Gélinas, Jean‐François, Hiva Azizi, Sascha Kießlich, et al.. (2020). Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures. Vaccine. 38(50). 7949–7955. 8 indexed citations

12.

Fausther‐Bovendo, Hugues & Gary Kobinger. (2020). Vaccine innovation spurred by the long wait for an Ebola virus vaccine. The Lancet Infectious Diseases. 21(4). 440–441. 8 indexed citations

13.

Lalle, Eleonora, Mirella Biava, Emanuele Nicastri, et al.. (2019). Pulmonary Involvement during the Ebola Virus Disease. Viruses. 11(9). 780–780. 8 indexed citations

14.

Nicastri, Emanuele, Gary Kobinger, Francesco Vairo, et al.. (2019). Ebola Virus Disease. Infectious Disease Clinics of North America. 33(4). 953–976. 35 indexed citations

15.

Mendoza, Emelissa J., Bryce M. Warner, Gary Kobinger, Nicholas H. Ogden, & David Safronetz. (2018). Baited vaccines: A strategy to mitigate rodent‐borne viral zoonoses in humans. Zoonoses and Public Health. 65(6). 711–727. 6 indexed citations

16.

Cimini, Eleonora, Concetta Castilletti, Alessandra Sacchi, et al.. (2017). Human Zika infection induces a reduction of IFN-γ producing CD4 T-cells and a parallel expansion of effector Vδ2 T-cells. Scientific Reports. 7(1). 6313–6313. 30 indexed citations

17.

Macciocchi, Daniele, Simone Lanini, Francesco Vairo, et al.. (2016). Short-term economic impact of the Zika virus outbreak.. PubMed. 39(4). 287–289. 41 indexed citations

18.

Vega, Marc-Antoine de La, et al.. (2016). Diagnosis and management of Ebola samples in the laboratory. Expert Review of Anti-infective Therapy. 14(6). 557–567. 10 indexed citations

19.

Ao, Zhujun, Xiaoxia Wang, Alexander Bello, et al.. (2010). Characterization of Anti-HIV Activity Mediated by R88-APOBEC3G Mutant Fusion Proteins in CD4 ⁺ T cells, Peripheral Blood Mononuclear Cells, and Macrophages. Human Gene Therapy. 22(10). 1225–1237. 13 indexed citations

20.

Strong, James E., Gary Wong, Shane Jones, et al.. (2008). Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway. Proceedings of the National Academy of Sciences. 105(46). 17982–17987. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact